WARRINGTON, Pa., Nov. 6, 2006 (PRIMEZONE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) a biotechnology company focused on developing its proprietary surfactant replacement therapies to address various respiratory conditions, announced today that the United States District Court for the Eastern District of Pennsylvania dismissed, without prejudice, the Consolidated Amended Class Action Complaint filed on August 9, 2006 against the Company and two of its executive officers.
